Author/Authors :
Jalilian, A Department of Medical Biochemistry - School of Medicine - Tehran University of Medical Sciences - Tehran, Iran , Doosti, M Department of Medical Biochemistry - School of Medicine - Tehran University of Medical Sciences - Tehran, Iran , Shariati, B School of Medicine - Tehran University of Medical Sciences - Tehran, Iran , Javadi, E Endocrinology and Metabolism Research Cente - Shariati Hospital - Tehran University of Medical Sciences - Tehran, Iran , Amiri, P Endocrinology and Metabolism Research Cente - Shariati Hospital - Tehran University of Medical Sciences - Tehran, Iran , Mohaghegh, A Division of Heart and vascular Diseases - Shariati Hospital - Tehran University of Medical Sciences - Tehran, Iran
Abstract :
The oxidation of low-density lipoproteins and cell membrane lipids is believed to play an
integral role in the development of fatty streak lesions, an initial step in coronary artery disease (CAD).
Paraoxonase-1 (PON1) is an enzyme associated with the high-density lipoprotein (HDL) particle. PON1
protects LDL from oxidative modification by hydrolyzing lipid peroxides, suggestive of a role for
PON1 in the development of CAD. The present study tested the hypothesis that Paraoxonase-1
promoter polymorphism T(–107)C could be a risk factor for severity of CAD in Iranian population.
Paraoxonase-1 promoter genotypes were determined in 300 consecutive subjects (> 40 years old) who
underwent coronary angiography (150 subjects with >50% stenosis served as cases [CAD+] and 150
subjects with < 20% stenosis served as controls [CAD-]). PON1 promoter genotypes were determined
by PCR and BSTU1 restriction enzyme digestion. CAD+ Subjects did not show any significant
differences in the distribution of PON1 promoter genotypes as compared to CAD- Subjects (P = 0.075).
However the analysis of PON1 promoter genotypes distribution showed a higher percentage of (-107)
TT among CAD+ compared with CAD- (P = 0.027). After controlling for other risk factors, the T(–
107)C polymorphism had interaction with age (P = 0.012), but did not show any interaction with other
risk factors such as BMI ,gender, smoking, diabetes, level of HDL-C, LDL-C, triglyceride and Total
cholesterol. These data suggest that the TT genotype may represent a genetic risk factor for Coronary
artery disease in Iranian population.